SOPH - SOPHiA GENETICS SA Revenue Growth Rate YoY (Last Twelve Months)

Demand for cloud-based genomic analysis in oncology is rising, as confirmed by the rolling annual sales growth rate, where the parameter value equals 24.20. SOPHiA GENETICS SA (SOPH) relies on an AI platform powered by a massive array of patient data. High barriers to entry are created by stringent privacy standards and a network effect that improves model accuracy as the user base expands.
SOPHiA GENETICS - analytical breakdowns and key metrics (SOPH)

This indicator measures the percentage change in revenue over the last twelve months relative to the same period last year, smoothing out short-term fluctuations to assess the true business momentum. By analyzing the year-over-year sales growth trajectory over the TTM, an investor can see how global clinician confidence in the SOPHiA GENETICS AI platform converts into actual market share expansion within bioinformatics.